The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective

by Brandon M. Meyers, Arndt Vogel, Paul Marotta, Petr Kavan, Laveena Kamboj, Janice Pan, Marc Geadah, David Trueman, Suthakar Sabapathy
Published 2021-01-01

Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury.

by Fei Fang, George Chu Liu, Xiaohua Zhou, Stuart Yang, Heather Naomi Reich, Vanessa Williams, Amanda Hu, Janice Pan, Ana Konvalinka, Gavin Yadram Oudit, James William Scholey, Rohan John
Published 2013-01-01

Health‐related quality‐of‐life analyses from a multicenter, randomized, double‐blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 m...

by Matthew H. Taylor, Sophie Leboulleux, Yury Panaseykin, Bhavana Konda, Christelle de LaFouchardiere, Brett G. M. Hughes, Andrew G. Gianoukakis, Young Joo Park, Ilia Romanov, Monika K. Krzyzanowska, Diana Garbinsky, Bintu Sherif, Jie Janice Pan, Terri A. Binder, Nicholas Sauter, Ran Xie, Marcia S. Brose
Published 2023-02-01